OBJECTIVE: Systemic lupus erythematosus (SLE) has one of the highest hospital readmission rates among chronic conditions. This study was undertaken to identify patient-level, hospital-level, and geographic predictors of 30-day hospital readmissions associated with SLE. METHODS: Using hospital discharge databases from 5 geographically dispersed states, we studied all-cause readmission of SLE patients between 2008 and 2009. We evaluated each hospitalization as a possible index event leading up to a readmission, our primary outcome. We accounted for clustering of hospitalizations within patients and within hospitals and adjusted for hospital case mix. Using multilevel mixed-effects logistic regression, we examined factors associated with 30-day readmission and calculated risk-standardized hospital-level and state-level readmission rates. RESULTS: We examined 55,936 hospitalizations among 31,903 patients with SLE. Of these hospitalizations, 9,244 (16.5%) resulted in readmission within 30 days. In adjusted analyses, age was inversely related to risk of readmission. African American and Hispanic patients were more likely to be readmitted than white patients, as were those with Medicare or Medicaid insurance (versus private insurance). Several clinical characteristics of lupus, including nephritis, serositis, and thrombocytopenia, were associated with readmission. Readmission rates varied significantly between hospitals after accounting for patient-level clustering and hospital case mix. We also found geographic variation, with risk-adjusted readmission rates lower in New York and higher in Florida as compared to California. CONCLUSION: We found that ~1 in 6 hospitalized patients with SLE were readmitted within 30 days of discharge, with higher rates among historically underserved populations. Significant geographic and hospital-level variation in risk-adjusted readmission rates suggests potential for quality improvement.
OBJECTIVE:Systemic lupus erythematosus (SLE) has one of the highest hospital readmission rates among chronic conditions. This study was undertaken to identify patient-level, hospital-level, and geographic predictors of 30-day hospital readmissions associated with SLE. METHODS: Using hospital discharge databases from 5 geographically dispersed states, we studied all-cause readmission of SLEpatients between 2008 and 2009. We evaluated each hospitalization as a possible index event leading up to a readmission, our primary outcome. We accounted for clustering of hospitalizations within patients and within hospitals and adjusted for hospital case mix. Using multilevel mixed-effects logistic regression, we examined factors associated with 30-day readmission and calculated risk-standardized hospital-level and state-level readmission rates. RESULTS: We examined 55,936 hospitalizations among 31,903 patients with SLE. Of these hospitalizations, 9,244 (16.5%) resulted in readmission within 30 days. In adjusted analyses, age was inversely related to risk of readmission. African American and Hispanic patients were more likely to be readmitted than white patients, as were those with Medicare or Medicaid insurance (versus private insurance). Several clinical characteristics of lupus, including nephritis, serositis, and thrombocytopenia, were associated with readmission. Readmission rates varied significantly between hospitals after accounting for patient-level clustering and hospital case mix. We also found geographic variation, with risk-adjusted readmission rates lower in New York and higher in Florida as compared to California. CONCLUSION: We found that ~1 in 6 hospitalized patients with SLE were readmitted within 30 days of discharge, with higher rates among historically underserved populations. Significant geographic and hospital-level variation in risk-adjusted readmission rates suggests potential for quality improvement.
Authors: Aimee O Hersh; Laura Trupin; Jinoos Yazdany; Peter Panopalis; Laura Julian; Patricia Katz; Lindsey A Criswell; Edward Yelin Journal: Arthritis Care Res (Hoboken) Date: 2010-08 Impact factor: 4.794
Authors: Sebastian Schneeweiss; Ari Robicsek; Richard Scranton; Dan Zuckerman; Daniel H Solomon Journal: J Clin Epidemiol Date: 2006-12-18 Impact factor: 6.437
Authors: Kristina L Demas; Brendan T Keenan; Daniel H Solomon; Jinoos Yazdany; Karen H Costenbader Journal: Semin Arthritis Rheum Date: 2010-04-08 Impact factor: 5.532
Authors: Gabriela Schmajuk; Edward Yelin; Eliza Chakravarty; Lorene M Nelson; Pantelis Panopolis; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2010-07 Impact factor: 4.794
Authors: Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone Journal: Arthritis Rheum Date: 2008-01
Authors: Jinoos Yazdany; Laura Trupin; Chris Tonner; R Adams Dudley; Joann Zell; Pantelis Panopalis; Gabriela Schmajuk; Laura Julian; Patricia Katz; Lindsey A Criswell; Edward Yelin Journal: J Gen Intern Med Date: 2012-05-17 Impact factor: 5.128
Authors: Jinoos Yazdany; Chris Tonner; Laura Trupin; Pantelis Panopalis; Joann Z Gillis; Aimee O Hersh; Laura J Julian; Patricia P Katz; Lindsey A Criswell; Edward H Yelin Journal: Arthritis Res Ther Date: 2010-05-12 Impact factor: 5.156
Authors: April Barnado; Carolyn Casey; Robert J Carroll; Lee Wheless; Joshua C Denny; Leslie J Crofford Journal: Arthritis Care Res (Hoboken) Date: 2017-04-10 Impact factor: 4.794
Authors: Candace H Feldman; Jinoos Yazdany; Hongshu Guan; Daniel H Solomon; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2015-12 Impact factor: 4.794
Authors: Christie M Bartels; Ann Chodara; Yi Chen; Xing Wang; W Ryan Powell; Fangfang Shi; Maria Schletzbaum; Ann M Sheehy; Farah A Kaiksow; Andrea L Gilmore-Bykovskyi; Shivani Garg; Menggang Yu; Amy J Kind Journal: Semin Arthritis Rheum Date: 2021-02-19 Impact factor: 5.431
Authors: Christine Anastasiou; Laura Trupin; David V Glidden; Jing Li; Milena Gianfrancesco; Stephen Shiboski; Gabriela Schmajuk; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2021-08-31 Impact factor: 5.178
Authors: Candace H Feldman; Cameron Speyer; Rachel Ashby; Bonnie L Bermas; Shamik Bhattacharyya; Eliza Chakravarty; Brendan Everett; Elizabeth Ferucci; Aimee O Hersh; Francisco M Marty; Joseph F Merola; Rosalind Ramsey-Goldman; Brad H Rovin; Mary Beth Son; Laura Tarter; Sushrut Waikar; Jinoos Yazdany; Joel S Weissman; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2021-01 Impact factor: 4.794